Publication of change in the total number of shares and votes in Diamyd
In connection with the exercise of employee stock options in the stock
option plan 2007/2010, 100,000 new shares of series B have been issued,
with support of underlying warrants that covers the company's
obligations under the plan. The shares have been placed with an
institutional investor.
After registration of the capital increase the share capital in Diamyd
Medical AB (publ.) will be 14,580,138.50 SEK. The total number of votes
will be 4,210,116 and the total number of shares will be 29,160,277,
divided among 1,437,876 shares of series A (1 vote) and 27,722,401
shares of series B (1/10 vote).
For more information, please contact:
Elisabeth Lindner, President and CEO Diamyd Medical AB (publ.)
Phone: +46 8 661 0026
For pictures and press material, please contact:
Andreas Ericsson, Diamyd Medical AB (publ.)andreas.ericsson@diamyd.com
Phone: +46 8 661 0026
